PhenomeX Yönetim

Yönetim kriter kontrolleri 1/4

PhenomeX CEO'su Siddhartha Kadia, Mar2022 tarihinde atandı, in görev süresi 1.58 yıldır. in toplam yıllık tazminatı $ 10.10M olup, şirket hissesi ve opsiyonları dahil olmak üzere 5.6% maaş ve 94.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.65% ine doğrudan sahiptir ve bu hisseler $ 644.07K değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.2 yıl ve 3.3 yıldır.

Anahtar bilgiler

Siddhartha Kadia

İcra Kurulu Başkanı

US$10.1m

Toplam tazminat

CEO maaş yüzdesi	5.6%
CEO görev süresi	1.6yrs
CEO sahipliği	0.6%
Yönetim ortalama görev süresi	1.2yrs
Yönetim Kurulu ortalama görev süresi	3.3yrs

Son yönetim güncellemeleri

Recent updates

Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

May 16

PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Apr 17

Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Aug 15

Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development

Jun 09

Berkeley Lights Q1 2021 Earnings Preview

May 10

CEO Tazminat Analizi

Siddhartha Kadia'un ücretlendirmesi PhenomeX'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2023	n/a	n/a	-US$125m
Mar 31 2023	n/a	n/a	-US$100m
Dec 31 2022	US$10m	US$567k	-US$98m
Sep 30 2022	n/a	n/a	-US$86m
Jun 30 2022	n/a	n/a	-US$85m
Mar 31 2022	n/a	n/a	-US$78m
Dec 31 2021	US$309k	n/a	-US$72m

Tazminat ve Piyasa: Siddhartha 'nin toplam tazminatı ($USD 10.10M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 649.63K ).

Tazminat ve Kazançlar: Siddhartha şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Siddhartha Kadia (53 yo)

1.6yrs

Görev süresi

US$10,096,450

Tazminat

Dr. Siddhartha Chandrakant Kadia, Ph D., M.S (Biomedical Engineering) & BE (Electronics and Telecommunication), has been Director at Berkeley Lights, Inc. since September 07, 2021 and serves as its Chief E...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Siddhartha Kadia	CEO & Director	1.6yrs	US$10.10m	0.65% $ 644.1k
Mehul Joshi	CFO & Principal Accounting Officer	1.3yrs	US$3.02m	0.065% $ 64.9k
Scott Chaplin	Chief Legal Officer & Corporate Secretary	1.1yrs	US$1.95m	0.020% $ 19.9k
Eric Hobbs	Executive Vice President of Integrations & Business Transformation	less than a year	US$1.78m	0.24% $ 242.6k
Suzanne Hatcher	Vice President of Communications & Investor Relations	no data	Veri yok	Veri yok
Lucas Vitale	Chief Human Resources Officer	1.5yrs	Veri yok	Veri yok
Rolando Brawer	Chief Business Officer	less than a year	Veri yok	Veri yok

1.2yrs

Ortalama Görev Süresi

49.5yo

Ortalama Yaş

Deneyimli Yönetim: CELL 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.2 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Siddhartha Kadia	CEO & Director	2.1yrs	US$10.10m	0.65% $ 644.1k
Dan Maydan	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Igor Khandros	Co-Founder & Independent Director	12.8yrs	US$225.01k	9.02% $ 9.0m
Elizabeth Nelson	Independent Director	4.1yrs	US$247.01k	0.076% $ 75.8k
Gregory Lucier	Independent Chairman of the Board	3.3yrs	US$370.09k	0.14% $ 135.8k
James E. Rothman	Chairman of Scientific Advisory Board	no data	US$345.01k	0.14% $ 144.0k
Ming Wu	Co-Founder & Member of Scientific Advisory Board	3.3yrs	Veri yok	Veri yok
John Chiminski	Independent Director	2.4yrs	US$237.51k	0.041% $ 40.8k
Eric Schadt	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Deepak Srivastava	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Jessica Hopfield	Independent Director	1.8yrs	US$233.01k	0.10% $ 103.4k
Adam Arkin	Member of Scientific Advisory Board	no data	Veri yok	Veri yok

3.3yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CELL 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.3 yıldır).

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2023/10/04 15:52
Gün Sonu Hisse Fiyatı	2023/09/29 00:00
Kazançlar	2023/06/30
Yıllık Kazançlar	2022/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

PhenomeX Inc. 8 Bu analistlerden 6, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Gaurav Goparaju	Berenberg
Mark Massaro	BTIG
Tycho Peterson	J.P. Morgan

PhenomeX Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

High number of new directors

Berkeley Lights, Inc. Announces Appointment of Scott Chaplin as Chief Legal Officer and Corporate Secretary

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Recent updates

Bruker Cellular Analysis, Inc. Files Form 15

Phenomex Announces Opto Memory B Discovery Human Workflow on the Beacon®? Optofluidic Platform

PhenomeX Inc. Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows

Phenomex Unveils Meteor Chips for Quantitative Bulk Analysis on the Isospark™ Platform to Revolutionize High Throughput Multiplexed Hands-Free Proteomics

Consensus EPS estimates upgraded to US$1.13 loss

Consensus EPS estimates fall by 22%

Price target decreased by 29% to US$4.00

Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL).

New major risk - Share price stability

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

PhenomeX Inc. to Report Q2, 2023 Results on Aug 14, 2023

PhenomeX Inc. Announces Lifting of the Stay in AbCellera Patent Infringement Case

PhenomeX Inc.(NasdaqGS:CELL) dropped from Russell Small Cap Comp Value Index

PhenomeX Receives a Notice from Nasdaq Regarding Minimum Bid Price Rule

PhenomeX Inc. Launches Beacon Quest™? Optofluidic System with Opto®? T Cell Profiling Workflows

Price target decreased by 31% to US$5.67

Consensus revenue estimates decrease by 16%, EPS upgraded

PhenomeX Inc. Launches Beacon Select Optofluidic System with Opto B Discovery Workflows

Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

PhenomeX Inc. Provides Earning Guidance for the Full Year of 2023

PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Full year 2022 earnings: EPS and revenues miss analyst expectations

Berkeley Lights, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Berkeley Lights, Inc. Provides Preliminary Revenue Guidance for the Year Ended December 31, 2022

Berkeley Lights, Inc. (NasdaqGS:BLI) announced a definitive agreement to acquire IsoPlexis Corporation (NasdaqGS:ISO) from a group of shareholders for $56.3 million.

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

High number of new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Berkeley Lights, Inc. Provides Revenue Guidance for the Year 2022

Berkeley Lights, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Berkeley Lights, Inc. Announces Appointment of Scott Chaplin as Chief Legal Officer and Corporate Secretary

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Consensus revenue estimates fall by 17%

Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Berkeley Lights, Inc. Provides Revenue Guidance for the Full Year 2022

Berkeley Lights, Inc. and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of A Patient-Derived T Cell Receptor Sequence Against A Cancer Neoantigen

Berkeley Lights, Inc. Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development

Berkeley Lights Inc. Announces Mehul Joshi as New Chief Financial Officer

Mehul Joshi joins Berkeley Lights as CFO

Berkeley Lights, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insider notifies of intention to sell stock

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to US$16.80

High number of new directors

Berkeley Lights, Inc., Annual General Meeting, May 26, 2022

Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer

Insider recently bought US$502k worth of stock

Berkeley Lights, Inc. Releases Upgrade to Its Software Suite for Beacon and Lightning Platforms

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Berkeley Lights, Inc. Reiterates Revenue Guidance for Full Year 2022

Price target decreased to US$30.40

Berkeley Lights, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Berkeley Lights, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Berkeley Lights, Inc

High number of new directors

Berkeley Lights, Inc. Provides Revenue Guidance for Full Year of 2021 and 2022

Berkeley Lights, Inc. to Showcase its Optofluidic Discovery Technology At 2021 Antibody Engineering & Therapeutics Conference

Berkeley Lights Grows Revenue But Operating Losses Mount

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Berkeley Lights, Inc

Independent Chairman of the Board recently bought US$500k worth of stock

Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$0.16 loss in 3Q 2020)

Berkeley Lights: Short Seller Report Raises A Few Legitimate Questions